GlassScriptPhysician profile
Jason Snyder
NPI 1447419320
$1,965.96
in general payments reported to CMS, 2019-2025
8 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $24.60 · 2022: $92.60 · 2023: $240 · 2024: $1,211 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,034 · Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,034.39 |
| Food and Beverage | $688.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,291.75 | 2019-2024 | |
| Boston Scientific Corporation | $184.15 | 2024-2025 | Spyglass Discover |
| Davol INC. | $177.04 | 2019-2023 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $150.96 | 2021-2025 | Sternalock Blu System |
| Kerecis Limited | $126.51 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Solventum Corporation | $19.94 | 2024 | Activ.A.C. |
| Shire North American Group INC | $15.61 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.